- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 14.05M sh |
| Stock Issued | Q1 2025 · Mar 31, 2025 | 3.72K sh |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $39.79M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $37.69M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.91M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.28M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.56M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.61M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $12.73M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $11.74M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $48.07M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $44.02M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.67M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $322.6K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.58M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.17 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.17 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $160.66K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $2.17M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $2.14M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.84M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $3.06M |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.9M |